An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses. Epidiolex is a nearly pure extract of cannabidiol, or CBD, with little of the tetrahydrocannabinol, or THC, that gets traditional pot users high.
Medical pot activists fear epilepsy drug could undercut them
by Research Team | Apr 18, 2016 | Health News | 0 comments